PROTECTION FROM GENITAL HERPES-SIMPLEX VIRUS TYPE-2 INFECTION BY VACCINATION WITH CLONED TYPE-1 GLYCOPROTEIN-D
PROTECTION FROM GENITAL HERPES-SIMPLEX VIRUS TYPE-2 INFECTION BY VACCINATION WITH CLONED TYPE-1 GLYCOPROTEIN-D
复制标题
DOI:
10.1126/science.2983428
复制
发表时间:
1985-01-01
期刊:
影响因子:
56.9
通讯作者:
LASKY, LA
中科院分区:
文献类型:
--
作者:
BERMAN, PW;GREGORY, T;LASKY, LA
Guinea pigs were vaccinated with truncated herpes simplex virus type-1 (HSV-1) glycoprotein D produced in the genetically engineered mammalian cell line gD10.2. Vaccinated animals formed antibodies that neutralized both HSV-1 and herpes simplex virus type 2 (HSV-2) in an in vitro neutralization assay. Vaccinated animals were challenged with HSV-2 by intravaginal infection. Animals that received the immunogen in Freund''s complete adjuvant were completely protected from the clinical manifestations of genital HSV-2 infection. Animals that received the immunogen incorporated in alum adjuvants were partly protected from clinical disease; the infections that did develop were significantly less severe than those that occurred in control animals injected with adjuvant alone. Thus, immunization with a purified viral protein can provide significant protection against primary genital infection by HSV-2 in guinea pigs.